Figure 2.The effects of agomelatine in Ang II-induced expression of VCAM-1 and ICAM-1 in HUVECs. HUVECs were treated with Ang II (1 μM) with or without agomelatine (10, 20 μM) for 24 h. (A) mRNA levels of VCAM-1 and ICAM-1; (B) Protein of VCAM-1 and ICAM-1 (##, **, &&, P<0.01 vs. vehicle control, Ang II, Ang II+ 10 μM agomelatine group).
